Anika Therapeutics reported $-3381000 in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abbott ABT:US USD 1.64B 135M
Agenus AGEN:US USD -41652000 3.32M
Agios Pharmaceuticals AGIO:US USD -91090000 6.55M
Arrowhead Research ARWR:US USD -83830000 10.92M
Clovis Oncology CLVS:US USD -44235000 15.15M
Enanta Pharmaceuticals ENTA:US USD -27048000 5.49M
Halozyme Therapeutics HALO:US USD 83.69M 49.63M
Immunogen IMGN:US USD -77429000 16.38M
Insmed INSM:US USD -122459000 21.52M
Integra Lifesciences IART:US USD 75.85M 2.65M
Intrexon XON:US USD -7614000 15.91M
Johnson & Johnson JNJ:US USD 6.27B 572M
Karyopharm Therapeutics KPTI:US USD -30839000 12.07M
Macrogenics MGNX:US USD -24955000 16.85M
Merit Medical Systems MMSI:US USD 18.66M 15.08M
Peregrine Pharmaceuticals PPHM:US USD -2684000 5.42M
Sangamo Biosciences SGMO:US USD -54894000 9.16M
Smith & Nephew PLC SN/:LN 335M 57M
Stryker SYK:US USD 1.23B 386M
Veracyte VCYT:US USD -9680000 2.25M
Xencor XNCR:US USD -38348000 10.35M
Zimmer Biomet Holdings Inc ZBH:US USD 382M 88.5M